These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32163436)

  • 61. Epidemic cholera among refugees in Malawi, Africa: treatment and transmission.
    Swerdlow DL; Malenga G; Begkoyian G; Nyangulu D; Toole M; Waldman RJ; Puhr DN; Tauxe RV
    Epidemiol Infect; 1997 Jun; 118(3):207-14. PubMed ID: 9207730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.
    Cook J; Jeuland M; Maskery B; Lauria D; Sur D; Clemens J; Whittington D
    J Policy Anal Manage; 2009; 28(1):6-28. PubMed ID: 19090047
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Global dynamics and optimal control of a cholera transmission model with vaccination strategy and multiple pathways.
    Song C; Xu R; Bai N; Tian XH; Lin JZ
    Math Biosci Eng; 2020 Jun; 17(4):4210-4224. PubMed ID: 32987576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modelling Optimal Control of Cholera in Communities Linked by Migration.
    Njagarah JB; Nyabadza F
    Comput Math Methods Med; 2015; 2015():898264. PubMed ID: 26246850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Awareness Programs on Cholera Dynamics: Two Modeling Approaches.
    Yang C; Wang X; Gao D; Wang J
    Bull Math Biol; 2017 Sep; 79(9):2109-2131. PubMed ID: 28748506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The importance of thinking beyond the water-supply in cholera epidemics: A historical urban case-study.
    Phelps MD; Azman AS; Lewnard JA; Antillón M; Simonsen L; Andreasen V; Jensen PKM; Pitzer VE
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006103. PubMed ID: 29176791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholera vaccines.
    Wkly Epidemiol Rec; 2001 Apr; 76(16):117-24. PubMed ID: 11338983
    [No Abstract]   [Full Text] [Related]  

  • 68. Epidemic cholera during refugee resettlement in Malawi.
    Hatch DL; Waldman RJ; Lungu GW; Piri C
    Int J Epidemiol; 1994 Dec; 23(6):1292-9. PubMed ID: 7721533
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.
    Ciglenecki I; Azman AS; Jamet C; Serafini M; Luquero FJ; Cabrol JC
    J Infect Dis; 2018 Oct; 218(suppl_3):S165-S166. PubMed ID: 30239901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improving immunization approaches to cholera.
    Saha A; Rosewell A; Hayen A; MacIntyre CR; Qadri F
    Expert Rev Vaccines; 2017 Mar; 16(3):235-248. PubMed ID: 27805467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modelling techniques in cholera epidemiology: A systematic and critical review.
    Anteneh LM; Lokonon BE; Kakaï RG
    Math Biosci; 2024 Jul; 373():109210. PubMed ID: 38777029
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modes of transmission of cholera in a newly infected population on an atoll: implications for control measures.
    McIntyre RC; Tira T; Flood T; Blake PA
    Lancet; 1979 Feb; 1(8111):311-4. PubMed ID: 84960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cholera in Makhachkala during the 1994 epidemic].
    Mamaeva SM; Moskvitina EA; Onishchenko GG; Adzieva RG; Kokushkin AM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():46-50. PubMed ID: 7771144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholera vaccines for the developing world.
    Lopez AL; Clemens JD; Deen J; Jodar L
    Hum Vaccin; 2008; 4(2):165-9. PubMed ID: 18414029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The epidemiological characteristics of cholera in the Republic of Dagestan. An assessment of the epidemic-control measures].
    Onishchenko GG; Lomov IuM; Moskvitina EA; Chiburaev VI; Liakhover ML; Rokhoev MR; Terent'ev AN; Asvarov BM; Chernyshev SN; Gadzhieva SZ
    Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():9-22. PubMed ID: 7771157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modelling cholera transmission dynamics in the presence of limited resources.
    Nyabadza F; Aduamah JM; Mushanyu J
    BMC Res Notes; 2019 Aug; 12(1):475. PubMed ID: 31370867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Impact of Water, Sanitation and Hygiene Interventions to Control Cholera: A Systematic Review.
    Taylor DL; Kahawita TM; Cairncross S; Ensink JH
    PLoS One; 2015; 10(8):e0135676. PubMed ID: 26284367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A note on dynamics of an age-of-infection cholera model.
    Wang J; Zhang R; Kuniya T
    Math Biosci Eng; 2016 Feb; 13(1):227-47. PubMed ID: 26776267
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Near real-time forecasting for cholera decision making in Haiti after Hurricane Matthew.
    Pasetto D; Finger F; Camacho A; Grandesso F; Cohuet S; Lemaitre JC; Azman AS; Luquero FJ; Bertuzzo E; Rinaldo A
    PLoS Comput Biol; 2018 May; 14(5):e1006127. PubMed ID: 29768401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.